Transcatheter aortic valve implantation with the new-generation Evolut R™
Tài liệu tham khảo
Abdel-Wahab, 2014, Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial, JAMA, 311, 1503, 10.1001/jama.2014.3316
Detaint, 2009, Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence, JACC Cardiovasc. Interv., 2, 821, 10.1016/j.jcin.2009.07.003
Hayashida, 2011, Transfemoral aortic valve implantation new criteria to predict vascular complications, JACC Cardiovasc. Interv., 4, 851, 10.1016/j.jcin.2011.03.019
Kappetein, 2012, Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2), Eur. J. Cardiothorac. Surg., 42, S45, 10.1093/ejcts/ezs533
Piazza, 2014, First-in-human experience with the Medtronic CoreValve Evolut R, EuroIntervention, 9, 1260, 10.4244/EIJV9I11A215
Popma, 2014, Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery, J. Am. Coll. Cardiol., 63, 1972, 10.1016/j.jacc.2014.02.556
Schroeter, 2012, Predictors of permanent pacemaker implantation after Medtronic CoreValve bioprosthesis implantation, Europace, 14, 1759, 10.1093/europace/eus191
Sellers, 1964, Left retrograde cardioangiography in acquired cardiac disease: technic, indications and interpretations in 700 cases, Am. J. Cardiol., 14, 437, 10.1016/0002-9149(64)90027-X
Sinning, 2012, Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation, J. Am. Coll. Cardiol., 59, 1134, 10.1016/j.jacc.2011.11.048
Vahanian, 2012, Guidelines on the management of valvular heart disease (version 2012), Eur. Heart J., 33, 2451, 10.1093/eurheartj/ehs109
Wohrle, 2015, Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve, Int. J. Cardiol., 195, 171, 10.1016/j.ijcard.2015.05.139
